🇺🇸 FDA
Pipeline program

Odomzo 200 mg hard capsules

Phase 2 small_molecule active

Quick answer

Odomzo 200 mg hard capsules for locally advanced basal cell carcinoma is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).

Program details

Company
Fondazione Telethon ETS
Indication
locally advanced basal cell carcinoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials